CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goodman, G. E.
Right arrow Articles by Gylys-Colwell, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goodman, G. E.
Right arrow Articles by Gylys-Colwell, I.

Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 4 389-396, Copyright © 1993 by American Association for Cancer Research


ARTICLES

The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with cigarette smokers

GE Goodman, GS Omenn, MD Thornquist, B Lund, B Metch and I Gylys-Colwell
Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.

In preparation for a phase IV lung cancer chemoprevention trial, we conducted a pilot trial of beta-carotene and retinol in high-risk smokers. Eligibility criteria were ages of 50-69 years, a smoking history of at least 20 pack-years, and either being a current smoker or having quit within the past 6 years. Participants were recruited by mailing an interest survey to 29,928 age-selected members of King County Medical Blue Shield. We randomized 1,029 women and men to one of four intervention arms: placebo, retinol, 25,000 international units/day; beta-carotene, 30 mg/day; or retinol plus beta-carotene. Participants were followed for side effects and adherence every 2 months either by a telephone call or a clinic visit. Blood was sampled for retinoid, carotenoid, and liver function analyses annually. beta-carotene and retinol were well tolerated during the follow-up period, which had a median of 1.5 years and a maximum of 3.3 years. Yellowing of the skin was seen in both beta-carotene arms. No differences were seen among arms or over time in incidence or severity of the other 15 monitored symptoms and signs or in serum liver function tests. Adherence was good: 83% of participants remained active on study at 1 year and 75% at 2 years. Serum beta-carotene increased from a prerandomization median concentration of 170 to 2100 ng/ml after 4 months of supplementation, and retinyl palmitate median levels more than tripled.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
CarcinogenesisHome page
C. Persson, S. Sasazuki, M. Inoue, N. Kurahashi, M. Iwasaki, T. Miura, W. Ye, S. Tsugane, and for the JPHC Study Group
Plasma levels of carotenoids, retinol and tocopherol and the risk of gastric cancer in Japan: a nested case-control study
Carcinogenesis, May 1, 2008; 29(5): 1042 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
L. B. Michaud, J. P. Karpinski, K. L. Jones, and J. Espirito
Dietary supplements in patients with cancer: Risks and key concepts, part 1
Am. J. Health Syst. Pharm., February 15, 2007; 64(4): 369 - 381.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
O. A. Aliyu, M. R. Cullen, M. J. Barnett, J. R. Balmes, B. Cartmel, C. A. Redlich, C. A. Brodkin, S. Barnhart, L. Rosenstock, L. Israel, et al.
Evidence for Excess Colorectal Cancer Incidence among Asbestos-exposed Men in the Beta-Carotene and Retinol Efficacy Trial
Am. J. Epidemiol., November 1, 2005; 162(9): 868 - 878.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. R. Cullen, M. J. Barnett, J. R. Balmes, B. Cartmel, C. A. Redlich, C. A. Brodkin, S. Barnhart, L. Rosenstock, G. E. Goodman, S. P. Hammar, et al.
Predictors of Lung Cancer among Asbestos-exposed Men in the {beta}-Carotene and Retinol Efficacy Trial
Am. J. Epidemiol., February 1, 2005; 161(3): 260 - 270.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. M. Alfano, R. C. Klesges, D. M. Murray, D. J. Bowen, A. McTiernan, M. W. Vander Weg, L. A. Robinson, B. Cartmel, M. D. Thornquist, M. Barnett, et al.
Physical Activity in Relation to All-Site and Lung Cancer Incidence and Mortality in Current and Former Smokers
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2233 - 2241.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, F. L. Meyskens Jr., G. S. Omenn, B. Valanis, and J. H. Williams Jr.
The Beta-Carotene and Retinol Efficacy Trial: Incidence of Lung Cancer and Cardiovascular Disease Mortality During 6-Year Follow-up After Stopping {beta}-Carotene and Retinol Supplements
J Natl Cancer Inst, December 1, 2004; 96(23): 1743 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
T. Kakizoe
Chemoprevention of Cancer - Focusing on Clinical Trials
Jpn. J. Clin. Oncol., September 1, 2003; 33(9): 421 - 442.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Ballew, B. A Bowman, R. M Russell, A. L Sowell, and C. Gillespie
Serum retinyl esters are not associated with biochemical markers of liver dysfunction in adult participants in the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994
Am. J. Clinical Nutrition, May 1, 2001; 73(5): 934 - 940.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Cartmel, T. E Moon, and N. Levine
Effects of long-term intake of retinol on selected clinical and laboratory indexes
Am. J. Clinical Nutrition, May 1, 1999; 69(5): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. S. Omenn, G. E. Goodman, M. D. Thornquist, J. Balmes, M. R. Cullen, A. Glass, J. P. Keogh, F. L. Meyskens, B. Valanis, J. H. Williams, et al.
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
N. Engl. J. Med., May 2, 1996; 334(18): 1150 - 1155.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1993 by the American Association for Cancer Research.